General MedicationsORALGeneric
AMVAZ
AMLODIPINE MALEATE
Standard Dose
5MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview AMVAZ is listed in Drugs@FDA under application 021435 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient AMLODIPINE MALEATE Form and strength TABLET;ORAL - 5MG Sponsor DR REDDYS LABS INC Submission history Latest submission status date: 2003-10-31 00:00:00.
Structured Monograph
Clinical summary
Approval overview AMVAZ is listed in Drugs@FDA under application 021435 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient AMLODIPINE MALEATE Form and strength TABLET;ORAL - 5MG Sponsor DR REDDYS LABS INC Submission history Latest submission status date: 2003-10-31 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.